Innovations In Neuromodulation: Venture Capital Panel. June 6, Tony Borowicz VP, Business Development

Transcription

1 Innovations In Neuromodulation: Venture Capital Panel June 6, 2015 Tony Borowicz VP, Business Development

2 Greatbatch As A Core Partner Batteries Capacitors Catheters Stimulation Leads Feedthroughs Device Enclosures & Cases Device Headers Device Assembly Advanced Coatings Introducers Orthopaedic Trays, Cases & Implants Header Enclosure Battery Feedthrough Stimulation Leads

3 Who We Serve 3

4 How We Partner Segment Offering Develops and commercializes high-value neural interface technology, components and systems for neuroscience and clinical applications Develops and manufactures complete medical devices, including active implantable medical devices for neuromodulation Designs and develops medical device technologies and system level platforms Designs and manufacturers medical devices and discrete technologies for CRM, neuromodulation, vascular, orthopaedic, and portable medical applications GB Ventures Makes strategic investments in markets, products, or technologies aligned with Greatbatch business categories or adjacent growth opportunities

5 R&D Neural Interface Develops advanced technologies and devices for Neuroscience & Neurostimulation research markets Basic science & technology studies Applied science & technology studies Clinical translational studies Thin-film electrodes NeuroNexus powers the R&D leading to next-generation neurostimulation markets, indications, and products

6 Device Development & Manufacturing Turn-key Medical Manufacturing Proven Development Platform Fully Integrated Manufacturing Facility Quality System Fast prototyping Full product design & development Testing & verification Low & medium volume manufacturing IDE, PMA, & CE Mark documentation Sensing Stimulation Communication Battery recharge Impedance measure FW download Other modules Class 7 & 8 clean areas Complete IPG assembly Packaging & sterilization ISO 13485:2003 certified (BSI) FDA 21 CFR Part 820 and registered CCC is dedicated to the development & manufacturing of complete real-time medical systems including active implantable medical devices

7 System Platform R&D Design & development of complete neurostimulation system platforms IPGs Leads Programmers Software Accessories QiG Group empowers the creative design, development and speed to market of new medical devices in strategic markets

8 Design & Manufacturing Component, value-added-assembly & full system manufacturing FDA Registered Facility / Regulatory: ISO13485:2003, CMDCAS, AIMD & MDD Greatbatch Medical is committed to the design and manufacture of critical technologies that enhance the reliability and performance of medical devices

9 Strategic Investments GB Ventures Minority Equity Strategic Investment Philosophy $2 5M targeted investments 3 5 targeted deals per year Typically board observer seat < 20% ownership equity positions nor maintain controlling interest Cardiac Neuromodulation Orthopaedics Vascular Portable Medical GB Ventures targets strategic investments in markets, products or technologies aligned with Greatbatch business categories or adjacent growth opportunities

10 How We Invest GB Ventures Creating a Win Win Partnership Cash Investment Equity Return Innovations & IP Product Development Services Manufacturing Capabilities Commercialization Avenues Royalty, Additional Equity, Alternate Fields of Use NRE Funding Exclusive Long Term Agreement Exclusive Distribution Agreement

11 Positioned for Neurostimulation Partnerships Early Stage Innovation Medical Device Components Medical Device Systems Equity investments Research Prototyping Component manufacturing for clinical trials Leads Batteries Feed throughs FDA experience Quality Systems Platform system reduces time and risk to market Other Neurostimulation indications GB Ventures

12 Our Story One-stop shop for long-term strategic partnerships from early stage investments through commercialization Multi-faceted mechanisms supporting: Investments Research Technology development Clinical trials Manufacturing History as world-class component supplier Next generation device development High volume manufacturing Unique Partnership Opportunity in the Field of Neuromodulation. Leverage our Capital, Technologies, Components, Platforms & Manufacturing

13 Thank you! Innovations In Neuromodulation: Venture Capital Panel June 6, 2015 Tony Borowicz VP, Business Development